Name | 4-L-Norleucine-alpha-Melanotropin |
---|---|
Synonyms |
L-Valinamide, N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-norleucyl-L-α-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-
(4-Norleucine)Alpha-Msh 4-Nle-Alpha-Msh N-Acetyl-L-seryl-L-tyrosyl-L-seryl-L-norleucyl-L-α-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valinamide Msh, 4-Nle-Alpha- N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-norleucyl-L-α-glutamyl-L-histidyl-L-phenylalanyl-N-(diaminomethylidene)-L-ornithyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valinamide |
Description | (Nle4)-α-MSH is a synthetic analogue of α-MSH (HY-P0252), a melanocyte-stimulating hormone. (Nle4)-α-MSH reversibly darkens frog skins and also exhibits prolonged activity after heat-alkali treatment[1]. |
---|---|
Related Catalog | |
Target |
tyrosinase; melanoma adenylate cyclase[1] |
In Vitro | (Nle4)-α-MSH shows a better bioactivity than α-MSH in frog skin bioassay, activation of mouse melanoma adenylate cyclase, and stimulation of mouse melanoma cell tyrosinase activity[1]. (Nle4)-α-MSH (0.1 nM; 0.5, 4, 8 h) stimulates tyrosinase activity in melanoma cells (NCTC 3960)[1]. (Nle4)-α-MSH (0.1 nM; 1-4 h) increases biological activity of melanotropins, indicating darkening response of frog skins[1]. (Nle4)-α-MSH (0.1 μg) also activates mouse melanoma adenylate cyclase[1]. |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C78H111N21O19 |
Molecular Weight | 1646.845 |
Exact Mass | 1645.836548 |
PSA | 642.98000 |
LogP | -0.80 |
Index of Refraction | 1.674 |